Showing 1 - 7 results of 7 for search 'Chieko Yoshida', query time: 0.04s
Refine Results
-
1
-
2
-
3
Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy by Shinya Sakata, Kosuke Imamura, Yuka Tajima, Yuiko Masuda, Ryo Sato, Chieko Yoshida, Shinichiro Okamoto, Sho Saeki, Yusuke Tomita, Takuro Sakagami
Published 2021-02-01
Article -
4
Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with... by Hidenori Ichiyasu, Yasumiko Sakamoto, Chieko Yoshida, Kazuhiko Sakamoto, Ryosuke Fujita, Go Nakayama, Hiroko Okabayashi, Sho Saeki, Shinichiro Okamoto, Hirotsugu Kohrogi
Published 2017-01-01
Article -
5
Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis by Moriyasu Anai, Chieko Yoshida, Kazutaka Ozono, Hirotsugu Furukawa, Yuko Ishimaru, Shinya Sakata, Koichi Saruwatari, Kei Muramoto, Yusuke Tomita, Sho Saeki, Hidenori Ichiyasu, Takuro Sakagami
Published 2022-04-01
Article -
6
Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonia... by Hiroko Okabayashi, Hidenori Ichiyasu, Sayuri Hirooka, Kimitaka Akaike, Keisuke Kojima, Takayuki Jodai, Yasumiko Sakamoto, Hideharu Ideguchi, Shohei Hamada, Chieko Yoshida, Susumu Hirosako, Shinichiro Okamoto, Hirotsugu Kohrogi
Published 2017-10-01
Article -
7
Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a re... by Hidenori Ichiyasu, Yuko Horio, Aiko Masunaga, Yohei Migiyama, Yasumiko Sakamoto, Takayuki Jodai, Hideharu Ideguchi, Hiroko Okabayashi, Shohei Hamada, Chieko Yoshida, Susumu Hirosako, Shinichiro Okamoto, Hirotsugu Kohrogi
Published 2017-07-01
Article